Muscle Atrophy, Physical Performance and Glucose Tolerance Post Stroke
NCT ID: NCT01302197
Last Updated: 2024-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
100 participants
OBSERVATIONAL
2011-04-13
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke.
NCT00430456
Exercise For Sub-acute Stroke Patients in Jamaica
NCT01392391
Neuromuscular and Biomechanical Control of Lower Limb Loading in Individuals With Chronic Stroke
NCT03694028
Skeletal Muscle Properties and the Metabolic Cost of Walking Post-stroke
NCT00721357
Task-oriented Training for Stroke: Impact on Function Mobility
NCT01322607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Knowledge of the skeletal muscle changes that occur in the early phases after stroke is essential to create new guidelines which incorporate exercise rehabilitation, much like cardiac rehabilitation, in order to facilitate and improve the health care of stroke survivors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
longitudinal follow-up after stroke
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 20-50 kg/m2
* Presenting within a month after stroke onset with residual hemiparetic deficit
* Patients must have adequate language and neurocognitive function to participate in testing and give adequate informed consent
Exclusion Criteria
* Unstable angina, CHF, severe PAD
* Dementia or untreated major depression
* Severe receptive or global aphasia
* Heavy alcohol use defined by greater than 3 oz. liquor, 12 oz of wine or 32 oz of beer daily
* anti-coagulation therapy with heparin, warfarin, or lovenox (anti-platelet therapy is permitted)
* bleeding disorder
* allergy to lidocaine
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baltimore VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alice S. Ryan, PhD
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alice S Ryan, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Maryland School of Medicine, Baltimore VA Research Service
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland Medical System
Baltimore, Maryland, United States
VA Maryland Health Care System, Baltimore
Baltimore, Maryland, United States
Kernan Hospital
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00042905
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.